Submitted by Anonymous (not verified) on 13 October 2026 - 16:01
Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 28, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 28, Status: Authorised